Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
2nd patient dies after Sarepta's DMD gene therapy Elevidys
Sarepta has suspended giving Elevidys to non-ambulatory DMD patients in the commercial setting while it seeks FDA approval of a risk mitigation plan.
Angus Liu
Jun 16, 2025 10:58am
Insmed's phase 2 PAH win sends stock soaring
Jun 10, 2025 11:59am
ASCO: Bristol CMO brushes off LAG-3 concern after melanoma flop
Jun 3, 2025 8:00am
J&J PARP path unclear in castration-sensitive prostate cancer subset
Jun 3, 2025 8:00am
ASCO: Amgen's Imdelltra prolongs life in small cell lung cancer
Jun 2, 2025 8:00am
ASCO: AZ, Daiichi flex Enhertu muscle in 2 cancers
Jun 2, 2025 8:00am
